• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore

By: StockStory
September 17, 2025 at 00:43 AM EDT

RPRX Cover Image

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Finding the right balance between safety and returns isn’t easy, which is why StockStory is here to help. Keeping that in mind, here is one low-volatility stock providing safe-and-steady growth and two that may not deliver the returns you need.

Two Stocks to Sell:

Royalty Pharma (RPRX)

Rolling One-Year Beta: 0.15

Pioneering a unique business model in the pharmaceutical industry since 1996, Royalty Pharma (NASDAQ: RPRX) acquires rights to receive portions of sales from successful biopharmaceutical products, providing funding to drug developers without conducting research itself.

Why Are We Hesitant About RPRX?

  1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 1.2% annually over the last two years
  2. Subscale operations are evident in its revenue base of $2.31 billion, meaning it has fewer distribution channels than its larger rivals

Royalty Pharma’s stock price of $36.30 implies a valuation ratio of 7.1x forward P/E. To fully understand why you should be careful with RPRX, check out our full research report (it’s free).

Ares Capital (ARCC)

Rolling One-Year Beta: 0.69

As one of the largest business development companies in the United States with over $20 billion in assets, Ares Capital (NASDAQ: ARCC) is a business development company that provides financing solutions to middle-market companies, primarily through direct loans and equity investments.

Why Should You Sell ARCC?

  1. Performance over the past two years shows its incremental sales were much less profitable, as its earnings per share fell by 3.6% annually

At $21.17 per share, Ares Capital trades at 10.5x forward P/E. Check out our free in-depth research report to learn more about why ARCC doesn’t pass our bar.

One Stock to Watch:

Euronet Worldwide (EEFT)

Rolling One-Year Beta: 0.93

Operating a global network of over 47,000 ATMs and 821,000 point-of-sale terminals across more than 60 countries, Euronet Worldwide (NASDAQ: EEFT) provides electronic payment solutions including ATM services, prepaid product processing, and international money transfer services.

Why Could EEFT Be a Winner?

  1. Annual revenue growth of 9.8% over the last five years was above the sector average and underscores its products and services value to customers
  2. Share repurchases have increased shareholder returns as its annual earnings per share growth of 11.9% exceeded its revenue gains over the last two years
  3. Market-beating return on equity illustrates that management has a knack for investing in profitable ventures

Euronet Worldwide is trading at $89.30 per share, or 8.5x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.

Stocks We Like Even More

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
This AI Chip Giant Could Be the Market’s Next Big Winner
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD TSM
Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD AVGO NVDA
Institutions Are Fueling CrowdStrike’s Next Leg Higher
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers CRWD DDOG ZS
Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMZN MSFT NVDA
This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD ASML NVDA

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.30
+4.85 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap